H1 Revenue - I Healthier

Bliss GVS Pharma acquisition: Proven strategies for growth

November 6, 2026 Ethan Cook

Bliss GVS Pharma acquisition reshaped the market, boosting H1 revenue to INR 14,609.15 million. Discover the impact and strategies involved.

You missed

Bliss GVS Pharma acquisition: Proven strategies for growth

November 6, 2026 Ethan Cook

API expansion strategy: A smart move for RPG Life Sciences

November 3, 2026 Ethan Cook

Biosimilars portfolio acquisition: Smart proven strategy

October 31, 2026 Ethan Cook

Cancer drug price cut: New rates for 543 brands revealed

October 29, 2026 Ethan Cook